Abstract:The development of the pharmaceutical industry is the cornerstone for safeguarding people’s lives and health. This study is based on a macro perspective and provides a comprehensive and in-depth comparison of the development trend of the pharmaceutical industry in China and abroad. It is pointed out that the global market size and strategic position of the pharmaceutical industry in various countries are constantly improving. Meanwhile, the development prospect of China’s pharmaceutical industry is broad, and the potential market space is large. On this basis, we further explore the development prospects and driving factors of China’s pharmaceutical industry, including changes in population structure and increased health awareness, increasing global competitive pressure, sustained government investment and support for the pharmaceutical industry, and increase in research and development (R & D) investment by leading enterprises. Moreover, from the perspective of medical practice, we propose the challenges faced by the pharmaceutical industry in five aspects: precision, safety, timeliness, affordability, and policy guarantee. Furthermore, in response to the challenges we face, we propose the following targeted countermeasures: (1) building and maintaining a refined large-populationbased cohort and data platform while providing sustained support; (2) accelerating the R & D and transformation of China’s internationally leading technologies in the pharmaceutical industry to strengthen original innovation and seize the market; (3) promoting the industrialization of pharmaceutical R & D by encouraging industry–education–research integration in the R & D and clinical trials stage, strengthening the evaluation ability in the evaluation stage, and improving guarantee services such as intellectual property protection in the promotion stage of innovative products; (4) improving multi-level medical security channels to strive for more sources of support and reduce the burden of self-payment for patients; and (5) enhancing the full chain of policy protection and implementation efficiency to effectively stimulate the development momentum of the medical industry. This study aims to provide a reference for the subsequent investment, policy formulation, and development decisions of China’s pharmaceutical industry.

Prospects of the development of pharmaceutical analysis in China based on the projects founded by NSFC

Development and prospect of China's pharmaceutical analysis discipline

Literature analysis on pharmaceutical care in China

Current Status And Prospects Of Research On Natural Products In China

Analysis of projects funded by the National Natural Science Foundation of China during the years of 2014–2018

Analysis and Prospect of the Pharmaceutical Industry Development Trend in China

ANALYSIS OF PEDIATRICS PROJECTS GRANTED BY NATIONAL NATURAL SCIENCE FOUNDATION IN RECENT 20 YEARS

[National Natural Science Foundation of China Promotes the Development of Chinese Medicine in China--an Analysis of Chinese Medicine Project Funded by National Natural Science Foundation of China in the Last Decade].

Comparison of application and funding of traditional Chinese medicine projects from 2014 to 2016 of National Natural Science Foundation of China

Analysis of major programs in the field of health science funded by the National Natural Science Foundation of China between the years 2010 and 2018

Biological screening of natural products and drug innovation in China

Analysis of National Natural Science Foundation of China Grants in Financial Years of 2010-2013 in Field of Laboratory Medicine and Future Perspectives

New Situation and New Strategies——research and Development and Internationalization of New Drugs and Health Products of Traditional Chinese Medicine

Research Analysis on Advanced Pharmaceutical Education in China and some Development Proposals

Analysis of the grants funded by National Natural Science Foundation on biomarker research in laboratory medicine during 2010 -2014 and future perspectives

The gap analysis between Chinese pharmaceutical academia and industry from 2000 to 2018

A Brief Introduction to Basic Concepts and Hot Points Ofbasic Researches on Pharmaceutics in China

Recent Advances in Drug Development and Regulatory Science in China

Analysis and Management of the National Natural Science Foundation of China in a Special Hospital

Public funding and private investment for R&D: a survey in China's pharmaceutical industry

Analysis of population health projects funded by Joint Fund of the National Natural Science Foundation of China between 2015 and 2019